Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • How to select cancer patients...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
How to select cancer patients for immunotherapy

How to select cancer patients for immunotherapy

Bibliographic Details
Main Authors: Per Pfeiffer, Camilla Qvortrup, Karin Holmskov Hansen
Format: Article
Language:English
Published: Elsevier 2021-01-01
Series:EBioMedicine
Online Access:http://www.sciencedirect.com/science/article/pii/S2352396420305600
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

http://www.sciencedirect.com/science/article/pii/S2352396420305600

Similar Items

  • High RBM3 expression is associated with an improved survival and oxaliplatin response in patients with metastatic colorectal cancer.
    by: Christina Siesing, et al.
    Published: (2017-01-01)
  • Evaluating the efficacy and safety of neoadjuvant pembrolizumab in patients with stage I–III MMR-deficient colon cancer: a national, multicentre, prospective, single-arm, phase II study protocol
    by: Ismail Gögenur, et al.
    Published: (2023-06-01)
  • Incidence, risk factors and clinical outcome of venous thromboembolism in non-small cell lung cancer patients receiving immune checkpoint inhibition
    by: Birgitte Bjørnhart, et al.
    Published: (2021-08-01)
  • A phase II study of daily encorafenib in combination with biweekly cetuximab in patients with BRAF V600E mutated metastatic colorectal cancer: the NEW BEACON study
    by: Martina Eriksen, et al.
    Published: (2022-12-01)
  • Exploiting the immunomodulatory properties of chemotherapeutic drugs to improve the success of cancer immunotherapy
    by: Kelly eKersten, et al.
    Published: (2015-10-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs